Open Label RCT for Chronic Severe AR : Entresto vs. CCB/ARB
Condition: Aortic Valve Insufficiency Interventions: Drug: Sacubitril-valsartan; Drug: Amlodipine-losartan Sponsor: Samsung Medical Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 28, 2022 Category: Research Source Type: clinical trials